Webinar: Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan

Veranstaltungsdatum: 1. Dezember 2021

Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan’.

About the webinar

Digital transformation has been reshaping the pharmaceutical industry. Today, AI has helped explore novel uses of existing drugs, develop new drugs, and accelerate R&D activity in the industry.

In Japan, patent eligibility of AI-related inventions is less strict than that in EP practice. When AI has been applied to pharmaceuticals, issues on inventive step, support requirements, and enable requirements often arise as points to be overcome.

Our speakers will explain patent eligibility on combinations of AI and pharmaceutical inventions, suggesting some practical points of the JPO Examination Guidelines. They will then give listeners insight into some case examples of AI-related pharmaceutical patents in Japan.

If you would like to view the webinar please contact marketing@hgf.com

Speakers

Dr. Masato Iida, Shiga

Fumio Takahashi, Shiga